From: Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
 | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
p value | HR | 95% CI | p value | HR | 95% CI | |
Gender | 0.471 | Â | Â | Â | Â | Â |
Age | 0.736 |  |  | 0.030 | 1.038 | 1.004–1.074 |
Tumor size | 0.527 | Â | Â | Â | Â | Â |
Tumor number | 0.446 | Â | Â | Â | Â | Â |
Vascular invasion | 0.659 | Â | Â | Â | Â | Â |
PLT | 0.357 | Â | Â | Â | Â | Â |
ALT | 0.542 | Â | Â | Â | Â | Â |
AFP | 0.050 | 1.000 | 1.000–1.000 |  |  |  |
HbsAg | 0.838 | Â | Â | Â | Â | Â |
HBV-DNA | 0.718 | Â | Â | Â | Â | Â |
Operative time | 0.203 | Â | Â | Â | Â | Â |
Liver cirrhosis | 0.010 | 2.922 | 1.287–6.634 | 0.046 | 2.670 | 1.019–6.996 |
Tumor differentiation | 0.387 | Â | Â | Â | Â | Â |
MVI | 0.859 | Â | Â | Â | Â | Â |
CELSR2 | < 0.01 | 10.924 | 5.159–23.131 | < 0.01 | 21.693 | 7.790–60.409 |